Quia Pharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Marcus Bosson
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8yrs |
| CEO ownership | 0.003% |
| Management average tenure | 3yrs |
| Board average tenure | 8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -SEK 14m |
| Mar 31 2024 | n/a | n/a | -SEK 15m |
| Dec 31 2023 | n/a | n/a | -SEK 17m |
| Sep 30 2023 | n/a | n/a | -SEK 18m |
| Jun 30 2023 | n/a | n/a | -SEK 20m |
| Mar 31 2023 | n/a | n/a | -SEK 20m |
| Dec 31 2022 | SEK 2m | SEK 2m | -SEK 20m |
Compensation vs Market: Insufficient data to establish whether Marcus's total compensation is reasonable compared to companies of similar size in the Swedish market.
Compensation vs Earnings: Insufficient data to compare Marcus's compensation with company performance.
CEO
Marcus Bosson (56 yo)
8yrs
Tenure
SEK 2,407,225
Compensation
Mr. Marcus Bosson serves as Chief Executive Officer of Bosson Investment AB. He has been Chief Executive Officer and Managing Director of QuiaPEG Pharmaceuticals Holding AB (publ) since 2017 and serves as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Medical Officer & Director | 5.3yrs | SEK 84.50k | no data | |
| MD, CEO & Director | no data | SEK 2.41m | 0.0026% SEK 439.4 | |
| Chief Financial Officer | 3yrs | no data | no data | |
| Head of Operations | 3yrs | SEK 939.87k | no data |
3.0yrs
Average Tenure
60.5yo
Average Age
Experienced Management: QUIA's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Medical Officer & Director | no data | SEK 84.50k | no data | |
| MD, CEO & Director | 8yrs | SEK 2.41m | 0.0026% SEK 439.4 | |
| Independent Director | 16yrs | SEK 125.00k | no data | |
| Independent Chairman of the Board | 4yrs | SEK 350.00k | no data |
8.0yrs
Average Tenure
67.5yo
Average Age
Experienced Board: QUIA's board of directors are considered experienced (8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 21:07 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Quia Pharma AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|